Mike Banville

Mike Banville is CEO and president of ALZpath, whose mission is to empower early, accurate and accessible Alzheimer’s disease diagnosis, transforming how the disease is detected, treated and prevented. He is a seasoned global operational leader with extensive experience driving business growth and transformation across diverse industries. As CEO at Game Plan, Sensable Health and SSB, and serving in key executive roles at IHS Markit, he delivered impactful results through strategic leadership. At IHS, he scaled the TMT division's revenue from $73 million to $152 million, led three strategic acquisitions, and managed 35 due diligence teams. Mike’s expertise spans go-to-market strategies, product management, enterprise sales, and marketing, with a proven ability to enhance scalability, profitability, and market positioning. He has also successfully integrated seven acquisitions across his leadership roles.